Skip to main content
. 2021 Sep 7;8:654867. doi: 10.3389/fmed.2021.654867

Figure 6.

Figure 6

The protective effect of GB1a on the intestinal mucosa (A) GB1a treatment upregulated the expression of genes ZO-1 and Occludin. (B) GB1a administration reduced the levels of fluorescein isothiocyanate (FITC)-dextran in the serum of UC mice and improved mucosal permeability in the colon. (C) Representative images of immunohistochemical staining of ZO-1 and Occludin and Claudin2 in mouse colon sections. (D,E) Ultrastructural morphology of the intestinal mucosal barrier. Data are presented as means ± SD (n = 7/group). *p < 0.05 and **p < 0.01. vs the DSS-incubated group.